Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (571-580 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 19, 2019
Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecanDavid M Goldenberg, Robert M Sharkey
Mabs|July 10, 2019
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cellsKamal Kishore Joshi, Wilson Phung, Guanghui Han, et al.
Mabs|May 4, 2019
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platformTorben Gjetting, Monika Gad, Camilla Fröhlich, et al.
Mabs|June 30, 2018
Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal AntibodiesQingrong Yan, Maggie Huang, Michael J Lewis, et al.
Mabs|July 24, 2018
Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantationJ I Rodriguez-Barbosa, M C Ferreras, L Buhler, et al.
Mabs|May 6, 2017
Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challengesMohammed Akli Ayoub, Pascale Crépieux, Markus Koglin, et al.
Mabs|July 11, 2017
Fabs-in-tandem immunoglobulin is a novel and versatile bispecific design for engaging multiple therapeutic targetsShiyong Gong, Fang Ren, Danqing Wu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
Mabs|June 5, 2019
Using bispecific antibodies in forced degradation studies to analyze the structure-function relationships of symmetrically and asymmetrically modified antibodiesAdam R Evans, Michael T Capaldi, Geetha Goparaju, et al.
Mabs|October 12, 2018
High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodiesT Noelle Lombana, Marissa L Matsumoto, Amy M Berkley, et al.
Pageof 184

Showing results (571-580 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 19, 2019
Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecanDavid M Goldenberg, Robert M Sharkey
Mabs|July 10, 2019
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cellsKamal Kishore Joshi, Wilson Phung, Guanghui Han, et al.
Mabs|May 4, 2019
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platformTorben Gjetting, Monika Gad, Camilla Fröhlich, et al.
Mabs|June 30, 2018
Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal AntibodiesQingrong Yan, Maggie Huang, Michael J Lewis, et al.
Mabs|July 24, 2018
Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantationJ I Rodriguez-Barbosa, M C Ferreras, L Buhler, et al.
Mabs|May 6, 2017
Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challengesMohammed Akli Ayoub, Pascale Crépieux, Markus Koglin, et al.
Mabs|July 11, 2017
Fabs-in-tandem immunoglobulin is a novel and versatile bispecific design for engaging multiple therapeutic targetsShiyong Gong, Fang Ren, Danqing Wu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
Mabs|June 5, 2019
Using bispecific antibodies in forced degradation studies to analyze the structure-function relationships of symmetrically and asymmetrically modified antibodiesAdam R Evans, Michael T Capaldi, Geetha Goparaju, et al.
Mabs|October 12, 2018
High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodiesT Noelle Lombana, Marissa L Matsumoto, Amy M Berkley, et al.
Pageof 184